Which companies overlap with National Center for AIDS/STD Control and Prevention, China CDC's portfolio?

Top competitors by shared drug class: Azienda Ospedaliera San Gerardo di Monza, Central Institute of Epidemiology, Moscow, Russia, Clinical Trial Agency of HIV Study Group, GlaxoSmithKline, Harvard School of Public Health (HSPH).

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/national-center-for-aids-std-control-and-prevention-china-cdc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

National Center for AIDS/STD Control and Prevention, China CDC — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

National Center for AIDS/STD Control and Prevention, China CDC pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Regimen:TDF+3TC+EFV	Regimen:TDF+3TC+EFV	marketed	Antiretroviral combination therapy (NRTI + NNRTI)	HIV reverse transcriptase	Infectious Disease / Virology
Regimen：BIC+FTC+TAF	Regimen：BIC+FTC+TAF	marketed	Antiretroviral combination therapy (integrase inhibitor + nucleoside reverse transcriptase inhibitors)	HIV integrase, HIV reverse transcriptase	Infectious Disease / Virology

Therapeutic area mix

Infectious Disease / Virology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Azienda Ospedaliera San Gerardo di Monza · 1 shared drug class
Central Institute of Epidemiology, Moscow, Russia · 1 shared drug class
Clinical Trial Agency of HIV Study Group · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Harvard School of Public Health (HSPH) · 1 shared drug class
Hospital Clinic of Barcelona · 1 shared drug class
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · 1 shared drug class
Juan A. Arnaiz · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for National Center for AIDS/STD Control and Prevention, China CDC:

Cite this brief

Drug Landscape (2026). National Center for AIDS/STD Control and Prevention, China CDC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/national-center-for-aids-std-control-and-prevention-china-cdc. Accessed 2026-05-18.